A Versatile Synthetic Strategy for the Preparation and Discovery of New Iminocyclitols as Inhibitors of Glycosidases
摘要:
A series of iminocyclitols was prepared using a versatile synthetic strategy, and their inhibition of glycosidases was evaluated using capillary electrophoresis. The study has demonstrated that remarkable specificities in enzyme inhibition can be achieved with small modifications on the aglycon side chain and the ring nitrogen. Among the compounds synthesized, (2R,3R,4R,5R)-N-methyl-2-(acetamidomethyl)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidine was found to be very potent; against beta-N-acetylhexosaminidase P with the K-i value of 80 nM.
Iminocyclitol inhibitors of hexoaminidase and glycosidase
申请人:The Scripps Research Institute
公开号:US06774140B1
公开(公告)日:2004-08-10
Designed iminocylitols that have potent inhibition activity with respect to hexominidases and glycosides are disclosed.
披露了设计的亚氨基糖醇,它们对己糖苷酶和苷具有强大的抑制活性。
IMINOCYCLITOL INHIBITORS OF HEXOAMINIDASE AND GLYCOSIDASE
申请人:THE SCRIPPS RESEARCH INSTITUTE
公开号:EP1181274B1
公开(公告)日:2010-11-10
SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF
申请人:Simon Fraser University
公开号:EP2344452A1
公开(公告)日:2011-07-20
Treatment of degenerative cartilage conditions in a mammal with Glycosidasc Inhibitors
申请人:Ichikawa Yoshitaka
公开号:US20070197471A1
公开(公告)日:2007-08-23
This invention relates to treating, preventing, and lessening the severity of conditions selected from the group consisting of osteoarthritis, rheumatoid arthritis, synovitis, subchondral bone edema, and cartilage degradation with administration of glycosidase inhibitors.
Selective Glycosidase Inhibitors and Uses Thereof
申请人:Vocadlo David Jaro
公开号:US20110301217A1
公开(公告)日:2011-12-08
The application relates to an immoalditol compound for selectively inhibiting glycosidases, a prodrug thereof and a pharmaceutical composition comprising the compound or the prodrug The application also relates to the use of the immoalditol compound for treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc Such diseases and disorders include neurodegenerative diseases, tauopathy, cancers, and cardiac disorders